Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study

Helena HL Borba1 Pharmaceutical Sciences Postgraduate Research Program, Department of Pharmacy

Astrid Wiens1 Pharmaceutical Sciences Postgraduate Research Program, Department of Pharmacy

Laiza M Steimbach1 Pharmaceutical Sciences Postgraduate Research Program, Department of Pharmacy

Fernanda S Tonin1 Pharmaceutical Sciences Postgraduate Research Program, Department of Pharmacy

Maria LA Pedroso2 Gastroenterology Service, Hospital de Clínicas, Federal University of Paraná

Cláudia AP Ivantes3 Guidance and Counseling Center, Curitiba City Hall, Curitiba, Paraná, Brazil

Fernando Fernandez-Llimos4 Department of Social Pharmacy, Faculty of Pharmacy, Research Institute for Medicines, University of Lisboa, Lisbon, Portugal

Roberto Pontarolo1 Pharmaceutical Sciences Postgraduate Research Program, Department of PharmacyCorrespondence[email protected]

show all

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)

Helena H.L. Borba, Ursula Rochau, Astrid Wiens, Gaby Sroczynski, Uwe Siebert, Vinicius L. Ferreira, Eimy Minowa & Roberto Pontarolo. (2019) Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective. Value in Health Regional Issues 20, pages 95-102.
Crossref

Xinnuo Xiong, Man Zhang, Quan Hou, Peixiao Tang, Zili Suo, Yujie Zhu & Hui Li. (2019) Solid dispersions of telaprevir with improved solubility prepared by co-milling: formulation, physicochemical characterization, and cytotoxicity evaluation. Materials Science and Engineering: C 105, pages 110012.
Crossref

Cirley Maria de Oliveira Lobato, Natalia Balassiano, Elodie Bomfim Hyppolito, Rafaela Liz Pellegrim Sanchez-Lermen, Izabelle Venturini Signorelli, Miguel Yasuo Tomita Nicacio, Alberto Pereira Firmino Filho, Thais Guaraná de Andrade, José Milton de Castro Lima, Talita Amorim de Arruda, Fernanda Schwanz Coutinho, Everton Felipe do Vale Araujo, Ticiana Mota Esmeraldo, Erlon Cortez, Rafaela Lorenzon Aragão Capeli, Melquior Brunno Mateus de Matos, Francisco Sérgio Rangel Pessoa, Hélder Cássio de Oliveira, Érico Antônio Gomes de Arruda, Patrícia Lofêgo Gonçalves, Antônio Haroldo Araújo Filho, Eliane Bordalo Cathalá Esberard & Francisco José Dutra Souto. (2018) Effectiveness of first-wave protease inhibitors in hepatitis C virus genotype 1 infection: a multicenter study in Brazil. Revista da Sociedade Brasileira de Medicina Tropical 51:1, pages 14-20.
Crossref

Xinnuo Xiong, Ruixue Gan, Zili Suo, Peixiao Tang, Shuangshuang Zhang, Yujie Zhu, Qiaomei Sun & Hui Li. (2018) Interactions between the antiviral drug telaprevir and human serum albumin: a combined study with spectroscopic methods and molecular modeling. New Journal of Chemistry 42:12, pages 9791-9800.
Crossref

Asaad Sharhani, Yadollah Mehrabi, Alireza Noroozi, Maryam Nasirian, Peter Higgs, Ahmad Hajebi, Behrooz Hamzeh, Nahid Khademi, Mehdi Noroozi, Ebrahim Shakiba & Koorosh Etemad. (2017) Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepatitis Monthly 17:10.
Crossref

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date